Nasdaq · Healthcare
InnovAge Holding Corp. (INNV)
As-reported financials and recent SEC filings for InnovAge Holding Corp., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$853.7M
Net income
$-30.3M
Net margin
-3.6%
Diluted EPS
$-0.22
ROE
-12.7%
P/E (TTM)
—
Market cap
$1.46B
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $853.7M | $763.9M | $688.1M | $698.6M | $637.8M |
| Gross profit | — | — | — | — | — |
| Operating income | $-29.8M | $-23.2M | $-49.4M | $-4.4M | $-12.3M |
| Net income | $-30.3M | $-21.3M | $-40.7M | $-6.5M | $-44.0M |
| Diluted EPS | $-0.22 | $-0.16 | $-0.30 | $-0.05 | $-0.36 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →32026-06-08
View on EDGAR →8-K2026-05-18
View on EDGAR →8-K2026-05-12
View on EDGAR →10-Q2026-05-08
View on EDGAR →8-K2026-05-05
View on EDGAR →Go deeper on INNV
Search InnovAge Holding Corp.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.